Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | DuoResp Spiromax 320micrograms/dose / 9micrograms/dose dry powder inhaler (Teva UK Ltd) |
| BNF code | 0302000K0BHABAU |
| Virtual Medicinal Product | Budesonide 400micrograms/dose / Formoterol 12micrograms/dose dry powder inhaler |
| Name | DuoResp Spiromax 320micrograms/dose / 9micrograms/dose dry powder inhaler |
| Abbreviated name | DuoResp Spiromax 320microg/dose / 9microg/dose dry pdr inh |
| Supplier | Teva UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Inhalation |
| Actual Medicinal Product Packs | |
| DuoResp Spiromax 320micrograms/dose / 9micrograms/dose dry powder inhaler (Teva UK Ltd) 60 dose | |
dm+d data retrieved from TRUD: release NHSBSA_12.1.0_20251208000001, imported on 9th December 2025 at 04:06:46.